Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (801) 801
life sciences & biomedicine (797) 797
humans (657) 657
transplantation (623) 623
hematology (581) 581
male (454) 454
female (437) 437
stem cells (416) 416
immunology (363) 363
hematopoietic stem cells (346) 346
haploidentical (344) 344
adult (342) 342
adolescent (287) 287
middle aged (286) 286
oncology (267) 267
hematopoietic stem cell transplantation - methods (258) 258
child (236) 236
hematopoietic stem cell transplantation (224) 224
treatment outcome (202) 202
young adult (199) 199
transplantation, homologous (192) 192
child, preschool (180) 180
leukemia (173) 173
t cells (167) 167
stem cell transplantation (165) 165
bone marrow (158) 158
transplantation conditioning - methods (153) 153
graft vs host disease - prevention & control (151) 151
cyclophosphamide (147) 147
hematopoietic stem cell transplantation - adverse effects (141) 141
aged (138) 138
haploidentical transplantation (133) 133
haplotypes (132) 132
hematology, oncology and palliative medicine (126) 126
analysis (122) 122
retrospective studies (121) 121
mortality (119) 119
biological and medical sciences (117) 117
medical sciences (115) 115
tissue donors (114) 114
haploidentical stem cell transplantation (112) 112
pediatrics (111) 111
transplantation conditioning (110) 110
transplants & implants (106) 106
graft vs host disease - etiology (104) 104
care and treatment (99) 99
hematologic neoplasms - therapy (98) 98
health aspects (96) 96
histocompatibility testing (96) 96
risk factors (95) 95
disease-free survival (94) 94
infant (93) 93
survival analysis (93) 93
graft survival (91) 91
graft-versus-host reaction (90) 90
bone marrow transplantation (88) 88
children (88) 88
hla antigens - immunology (88) 88
graft-versus-host disease (86) 86
transplantation, haploidentical - methods (85) 85
recurrence (84) 84
biophysics (82) 82
surgical procedures, operative (82) 82
graft vs host disease - immunology (81) 81
cancer (80) 80
immunotherapy (77) 77
research (77) 77
cyclophosphamide - therapeutic use (76) 76
histocompatibility (75) 75
hemopoiesis (74) 74
haploidentical hematopoietic stem cell transplantation (73) 73
relapse (70) 70
leukemia, myeloid, acute - therapy (69) 69
acute myeloid leukemia (67) 67
patients (67) 67
t-lymphocytes - immunology (67) 67
follow-up studies (66) 66
killer cells, natural - immunology (66) 66
survival rate (66) 66
transplantation, haploidentical (66) 66
patient outcomes (65) 65
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (64) 64
histocompatibility antigens (64) 64
hla histocompatibility antigens (64) 64
immunosuppressive agents - therapeutic use (64) 64
leukemia - therapy (64) 64
transfusions. complications. transfusion reactions. cell and gene therapy (64) 64
bone marrow, stem cells transplantation. graft versus host reaction (63) 63
unrelated donors (62) 62
histocompatibility antigen hla (60) 60
acute disease (59) 59
lymphocytes t (58) 58
lymphocyte depletion (57) 57
incidence (56) 56
graft vs host disease - mortality (55) 55
haploidy (54) 54
immune reconstitution (53) 53
medical research (52) 52
hematologic and hematopoietic diseases (50) 50
medicine & public health (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1090) 1090
German (10) 10
French (9) 9
Japanese (9) 9
Chinese (7) 7
Russian (3) 3
Polish (2) 2
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard‐risk acute lymphoblastic leukaemia in first complete remission
by Han, Li‐Jie and Wang, Yu and Fan, Zhi‐Ping and Huang, Fen and Zhou, Jian and Fu, Yue‐Wen and Qu, Hong and Xuan, Li and Xu, Na and Ye, Jie‐Yu and Bian, Zhi‐Lei and Song, Yong‐Ping and Huang, Xiao‐Jun and Liu, Qi‐Fa
British journal of haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 120 - 130
standard‐risk | first complete remission | haematopoietic stem cell transplantation | haploidentical donor | acute lymphoblastic leukaemia | standard-risk | Life Sciences & Biomedicine | Hematology | Science & Technology | Haplotypes | Recurrence | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Transplantation, Homologous | Incidence | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Retrospective Studies | Graft vs Host Disease - diagnosis | Graft vs Host Disease - etiology | Siblings | Graft Survival | Treatment Outcome | Combined Modality Therapy | Remission Induction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Survival Analysis | Graft vs Host Disease - prevention & control | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Adults | Transplantation | Comparative analysis | Hematopoietic stem cells | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia
by How, Joan and Slade, Michael and Vu, Khoan and DiPersio, John F and Westervelt, Peter and Uy, Geoffrey L and Abboud, Camille N and Vij, Ravi and Schroeder, Mark A and Fehniger, Todd A and Romee, Rizwan
Biology of blood and marrow transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 4, pp. 648 - 653
Hematology, Oncology and Palliative Medicine | Active disease | Acute myeloid leukemia | Haploidentical transplantation | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Age Factors | Hematopoietic Stem Cell Transplantation - standards | Humans | Middle Aged | Male | Hematopoietic Stem Cell Transplantation - mortality | Transplantation, Haploidentical - mortality | Cyclophosphamide - therapeutic use | Graft vs Host Disease | Young Adult | Transplantation, Haploidentical - methods | Adult | Female | Retrospective Studies | Leukemia, Myeloid, Acute - therapy | Risk Factors | Treatment Outcome | Leukemia, Myeloid, Acute - mortality | T-Lymphocytes - cytology | Survival Analysis | Aged | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Haploidentical - standards | Histocompatibility | Tissue Donors - supply & distribution | Cyclophosphamide | T cells | Hematopoietic stem cells | Analysis | Mortality | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation
by Ciurea, Stefan O and Cao, Kai and Fernadez-Vina, Marcelo and Kongtim, Piyanuch and Malki, Monzr Al and Fuchs, Ephraim and Luznik, Leo and Huang, Xiao-Jun and Ciceri, Fabio and Locatelli, Franco and Aversa, Franco and Castagna, Luca and Bacigalupo, Andrea and Martelli, Massimo and Blaise, Didier and Handgretinger, Rupert and Roy, Denis-Claude and O'Donnell, Paul and Bashey, Asad and Lazarus, Hillard M and Ballen, Karen and Savani, Bipin N and Mohty, Mohamad and Nagler, Arnon
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 05/2018, Volume 53, Issue 5, pp. 521 - 534
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Humans | Isoantibodies - analysis | Hematopoietic Stem Cell Transplantation - adverse effects | Transplantation, Haploidentical - adverse effects | Bone Marrow Transplantation - adverse effects | HLA Antigens - immunology | Treatment Outcome | Graft Rejection - immunology | Tissue Donors | Viral antibodies | Usage | Analysis | Antibodies | Practice guidelines (Medicine) | Bone marrow | Research | Hematopoietic stem cells | Antigens | Cell survival | Transplants & implants | Progenitor cells | Blood | Hemopoiesis | Rejection | Isoimmunization | Offspring | Grafts | Histocompatibility antigen HLA | Females | Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey
by Niederwieser, D and Baldomero, H and Szer, J and Gratwohl, M and Aljurf, M and Atsuta, Y and Bouzas, L.F and Confer, D and Greinix, H and Horowitz, M and Iida, M and Lipton, J and Mohty, M and Novitzky, N and Nunez, J and Passweg, J and Pasquini, M.C and Kodera, Y and Apperley, J and Seber, A and Gratwohl, A and Worldwide Network Blood Marrow Tra and for the Worldwide Network of Blood and Marrow Transplantation (WBMT)
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 06/2016, Volume 51, Issue 6, pp. 778 - 785
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Hematopoietic Stem Cell Transplantation - statistics & numerical data | Hematopoietic Stem Cell Transplantation - utilization | Humans | Bone Marrow Transplantation | Global Health - statistics & numerical data | Surveys and Questionnaires | Tissue Donors | Transplantation, Haploidentical | Peripheral Blood Stem Cell Transplantation | Transplantation, Homologous | Cord Blood Stem Cell Transplantation | Surveys | Health care industry | Forecasts and trends | Medical statistics | Hematopoietic stem cells | Usage | Analysis | Stem cells | Research | Data entry | Index Medicus | emerging technologies | Non Governmental Organization | SWOT analysis | Worldwide Network for Blood and Marrow Transplantation WBMT | global | transplant rates | hematopoietic stem cell transplantation (HSCT) | haploidentical transplants | cord blood transplants | trends | WHO
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Hematopoietic stem cell transplantation in Europe 2014 : more than 40 000 transplants annually
by Passweg, J. R and Baldomero, H and Bader, P and Bonini, C and Cesaro, S and ger, P and Duarte, R. F and Dufour, C and Kuball, J and Farge-Bancel, D and Gennery, A and Kröger, N and Lanza, F and Nagler, A and Sureda, A and Mohty, M and for the European Society for Blood and Marrow Transplantation (EBMT)
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 02/2016, Volume 51, Issue 6, pp. 786–792 - 792
Hematology | Transplantation | Journal Article | Amyloidosis - therapy | Hematopoietic Stem Cell Transplantation - trends | Europe | Hematopoietic Stem Cell Transplantation - statistics & numerical data | Humans | Patient Care Team - trends | Cord Blood Stem Cell Transplantation - statistics & numerical data | Transplantation, Autologous | Anemia, Aplastic - therapy | Transplantation, Homologous | Patient Care Team - statistics & numerical data | Neoplasms - therapy | Hematopoietic Stem Cell Transplantation - utilization | Tissue Donors - statistics & numerical data | Surveys and Questionnaires | Hematopoietic Stem Cell Transplantation - methods | Transplantation, Haploidentical | Fetal blood | Usage | Research | Hematopoietic stem cells | Stem cells | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Alternative donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders
by Klein, Orly R., MD and Chen, Allen R., MD, PhD, MHS and Gamper, Christopher, MD, PhD and Loeb, David, MD, PhD and Zambidis, Elias, MD, PhD and Llosa, Nicolas, MD and Huo, Jeffrey, MD, PhD and Dezern, Amy E., MD, MHS and Steppan, Diana, MD and Robey, Nancy, PA and Jo Holuba, Mary, MSN, RN, CRNP and Cooke, Kenneth R., MD and Symons, Heather J., MD, MHS
Biology of blood and marrow transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 5, pp. 895 - 901
Hematology, Oncology and Palliative Medicine | Bone marrow failure syndromes | Reduced-intensity conditioning | Cyclophosphamide | HLA-haploidentical | Immunodeficiency | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Cyclophosphamide - administration & dosage | Humans | Child, Preschool | Hematopoietic Stem Cell Transplantation | Infant | Male | Adolescent | Adult | Female | Graft vs Host Disease - prevention & control | Unrelated Donors | Transplantation Conditioning | Mycophenolic Acid - administration & dosage | Child | Tacrolimus - administration & dosage | Antimitotic agents | Mortality | Stem cells | Bone marrow | Children | Antineoplastic agents | Health aspects | Hematopoietic stem cells | Immunosuppressive agents | Index Medicus | cyclophosphamide | immunodeficiency | bone marrow failure syndromes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors
by Solomon, Scott R and Sizemore, Connie A and Sanacore, Melissa and Zhang, Xu and Brown, Stacey and Holland, H. Kent and Morris, Lawrence E and Bashey, Asad
Biology of blood and marrow transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 7, pp. 1299 - 1307
Hematology, Oncology and Palliative Medicine | Stem cell transplantation | Myeloablative | Total body irradiation | Haploidentical | Peripheral blood stem cells | Transplantation | Immunology | Life Sciences & Biomedicine | Hematology | Science & Technology | Haplotypes | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Recurrence | Whole-Body Irradiation | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Risk | Hematologic Neoplasms - pathology | Graft vs Host Disease - immunology | Cyclophosphamide - therapeutic use | Graft vs Host Disease - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Graft vs Host Disease - etiology | Acute Disease | Histocompatibility Testing | Transplantation, Isogeneic | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Survival Analysis | Graft vs Host Disease - prevention & control | Hematologic Neoplasms - immunology | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Chronic Disease | Leukemia | Immunotherapy | Mortality | Stem cells | Lymphomas | Mycophenolate mofetil | T cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin e patients from haploidentical donors
by Anurathapan, U and Hongeng, S and Pakakasama, S and Sirachainan, N and Songdej, D and Chuansumrit, A and Charoenkwan, P and Jetsrisuparb, A and Sanpakit, K and Rujkijyanont, P and Meekaewkunchorn, A and Lektrakul, Y and Iamsirirak, P and Surapolchai, P and Satayasai, W and Sirireung, S and Sruamsiri, R and Wahidiyat, P.A and Ungkanont, A and Issaragrisil, S and Andersson, B.S
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 06/2016, Volume 51, Issue 6, pp. 813 - 818
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | beta-Thalassemia - therapy | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Peripheral Blood Stem Cell Transplantation - mortality | Graft Survival | Infant | Survival Rate | Blood Component Removal | Hematopoietic Stem Cell Transplantation - mortality | Transplantation, Haploidentical - mortality | Young Adult | Disease-Free Survival | Homozygote | Transplantation, Haploidentical - methods | Adolescent | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning - methods | Child | Hemoglobin E | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation
by Gaballa, Sameh and Ge, Isabell and El Fakih, Riad and Brammer, Jonathan E and Kongtim, Piyanuch and Tomuleasa, Ciprian and Wang, Sa A and Lee, Dean and Petropoulos, Demetrios and Cao, Kai and Rondon, Gabriela and Chen, Julianne and Hammerstrom, Aimee and Lombardi, Lindsey and Alatrash, Gheath and Korbling, Martin and Oran, Betul and Kebriaei, Partow and Ahmed, Sairah and Shah, Nina and Rezvani, Katayoun and Marin, David and Bashir, Qaiser and Alousi, Amin and Nieto, Yago and Qazilbash, Muzaffar and Hosing, Chitra and Popat, Uday and Shpall, Elizabeth J and Khouri, Issa and Champlin, Richard E and Ciurea, Stefan O
Cancer, ISSN 0008-543X, 11/2016, Volume 122, Issue 21, pp. 3316 - 3326
hematologic malignancies | haploidentical transplantation | graft‐versus‐host disease | post‐transplantation cyclophosphamide | 9/10 matched unrelated donors | post-transplantation cyclophosphamide | graft-versus-host disease | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic Neoplasms - therapy | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclophosphamide - therapeutic use | Transplantation, Homologous | Feasibility Studies | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Unrelated Donors | Drug Therapy, Combination | Graft vs Host Disease - etiology | Histocompatibility Testing | Tacrolimus - therapeutic use | Mycophenolic Acid - therapeutic use | Adolescent | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Prevention | Usage | Cyclophosphamide | Clinical trials | Graft versus host reaction | Transplantation | Hematopoietic stem cells | Index Medicus | Abridged Index Medicus | 10 matched unrelated donors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights